BPC-157 is a synthetic research peptide derived from a gastric protein fragment, supplied as a lyophilized powder in BC2 (2mg 10 vials), BC5 (5mg 10 vials), and BC10 (10mg 10 vials)
separate vials let you adjust each peptide's dose independently
Delivery vehicles (liposomes, nanoparticles, microneedling) are used specifically to overcome this barrier
In a rat model of intervertebral disc degeneration, MOTS-c injection preserved disc height (82.4% versus 58.7% in the untreated group), restored MRI signals indicating improved disc hydration, and reduced histological degeneration scores by 44% compared to untreated controls
MRI, metabolic screening, and genetic testing should be performed as soon as possible in patients with infantile seizures to establish an early diagnosis and prevent neurologic sequelae with timely and effective treatment [79]
High-purity research compounds for laboratory and scientific use only not for human or veterinary administration